Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Double-component medicine for treating fatty liver and preparation method thereof

A fatty liver and formula technology is applied in the preparation of the drug and the field of double-preparation drugs for the treatment of fatty liver, which can solve the problems of safety in use, less adverse reactions, unsuitability for long-term use, etc. The effect of improving the extraction content

Active Publication Date: 2014-06-18
EMEISHAN HONGSHENG PHARMA
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the existing drugs for the treatment of fatty liver are not suitable for long-term use, and cannot simultaneously achieve the characteristics of stable effect, safe use, and small adverse reactions

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] First, extracts of various substances are obtained, and the extraction steps of the extracts are as follows:

[0033] (1) Remove impurities from the substances that need to be extracted; such as the extract of tai wu medicine, take out the medicinal part of tai wu medicine;

[0034] (2) Pulverize the material from which impurities have been removed; that is, pulverize it to 20 meshes through a pulverizer;

[0035] (3) Put it in the extraction tank according to the ratio of 1Kg substance to 10L water, and reflux for 20-30 minutes to obtain the extract; the extraction temperature is 100°C;

[0036] (4) Pump the extract into a concentration tank, and concentrate the extract, that is, use a conventional concentration method in the field of traditional Chinese medicine to concentrate the extract at about 90°C;

[0037] (5) The concentrated extract is spray-dried to obtain the tai wu medicine extract.

[0038] Various extracts in formula A and formula B are all obtained by ...

Embodiment 2

[0044] Prescription A: 3 parts of tai wu yao extract, 2 parts of salvia miltiorrhiza extract, 4 parts of rhubarb extract, 3 parts of panax notoginseng powder, 2 parts of clematis extract, 4 parts of black aconite, 3 parts of eucommia extract, 2 parts of Achyranthes knuckle extract, 3 parts of Bupleurum extract, 2 parts of Chuanxiong extract, 1 part of Wulingzhi, 4 parts of pearl powder, 2 parts of artificial bezoar, 3 parts of borneol, 14 parts of Ganoderma lucidum spore powder, 10 parts of chitosan oligosaccharide 5 parts of sophora flavescens extract, 3 parts of grape seed extract, 4 parts of resveratrol extract, 5 parts of ginseng extract, 7 parts of epimedium extract, 13 parts of desmodium extract, 13 parts of Hedyotis diffusa 23 parts of extract, 13 parts of Scutellaria barbata extract, 3 parts of vitamin C,

[0045] Prescription B: 10 parts of raw hawthorn extract, 13 parts of fenugreek extract, 7 parts of astragalus extract, 8 parts of Clematis extract, 4 parts of jujub...

Embodiment 3

[0047] Recipe A: 1 part of Taiwu medicine extract, 3 parts of Danshen extract, 3 parts of Yuanhu extract, 3 parts of Panax notoginseng powder, 3 parts of Clematis clematis extract, 2 parts of black aconite, 3 parts of Eucommia extract, 4 parts of Achyranthes knuckle extract, 1 part of Bupleurum extract, 3 parts of Chuanxiong extract, 2 parts of Wulingzhi, 3 parts of pearl powder, 4 parts of artificial bezoar, 1 part of borneol, 20 parts of Ganoderma lucidum spore powder, 8 parts of chitosan oligosaccharide 5 parts of sophora flavescens extract, 3 parts of grape seed extract, 2 parts of resveratrol extract, 4 parts of ginseng extract, 5 parts of epimedium extract, 12 parts of desmodium extract, 12 parts of Hedyotis diffusa 13 parts of extract, 11 parts of Scutellaria barbata extract, 4 parts of vitamin C,

[0048] Prescription B: 27 parts of raw hawthorn extract, 14 parts of fenugreek extract, 10 parts of astragalus extract, 4 parts of Clematis extract, 7 parts of jujube extrac...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a double-component medicine for treating fatty liver and a preparation method thereof. The invention mainly solves the problem that the existing medicine for treating fatty liver is not suitable for long-term taking and can not simultaneously achieve stable effect, high application safety and small adverse reaction. The double-component medicine disclosed by the invention is prepared from a component A and a component B, wherein the component A is prepared from combined spicebush root extract, rhizoma corydalis extract, pseudo-ginseng powder, radix clematidis extract, black monkshood, eucommia extract and the like; and the component B is prepared from radix rehmanniae preparata extract, safflower extract, radix bupleuri extract, radix asparagi extract, radix ophiopogonis extract, radix cyathulae extract and the like. The invention also provides a preparation method of the double-component medicine. The invention is suitable for long-term taking, and has the advantages of stable effect, high application safety, small adverse reaction and the like.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition for treating fatty liver, specifically a double-prescription medicine using Chinese herbal medicine as a raw material for treating fatty liver, and also relates to a preparation method of the medicine. Background technique [0002] The main clinical features of fatty liver are right hypochondriac pain, discomfort, and fatigue. The theory of traditional Chinese medicine believes that the main pathogenesis of this disease is internal stagnation of phlegm dampness and stagnation of qi stagnation due to eating disorders, stagnation of liver qi, accumulation of dampness and heat, and injury from poisoning. The location of the disease is mainly in the liver, involving the spleen, stomach, and gallbladder. The main pathological products are phlegm retention, blood stasis, and qi stagnation. The nature of the disease belongs to the deficiency of the root and the excess of the superficial syn...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/90A61K36/87A61K9/16A61K9/20A61P1/16A61K31/375A61K31/045A61K31/05A61K35/24A61K35/413A61K35/56A61K35/618
Inventor 余泽民刘芳郑鹰刘玉琴刘志刚
Owner EMEISHAN HONGSHENG PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com